Let’s work  together now
09 Nov 2017 – 16:29 | No Comment

As extremists are increasingly using the internet to radicalise the vulnerable and marginalised online with their poisonous ideology, the European Commissioner for the Security Union, Julian King raises the bar in Europe’s fight against online …

Read the full story »
International

EU Health

Transport

Circular Economy

Climate Change

Home » Archive by Category

Articles in Lung Cancer

Recent advances in personalised medicine in lung cancer – how can the benefits be leveraged throughout Europe?
14 Jul 2017 – 09:20
Recent advances in personalised medicine in lung cancer – how can the benefits be leveraged throughout Europe?

Michael Koehler, Commercial Portfolio Lead and Jason Almond, Brand Director, Oncology International Developed Markets at Pfizer discuss why it is imperative to support routine biomarker testing for lung cancer in Europe
Despite the highest mortality rates …

Clinical and policy cooperation important in fight against cancer
08 Dec 2016 – 17:30
Clinical and policy  cooperation important in fight against cancer

While the work done by the European Parliament’s informal group MEP’s against Cancer and the European Partnership for Action Against Cancer will continue to develop on cancer prevention in Europe and improve policy between member …

How do we solve the hardest challenges in cancer?
06 Dec 2016 – 17:22
How do we solve the hardest  challenges in cancer?

Cancer Research UK has made lung cancer a priority and has increased funding towards the deadly disease as against other cancer types.   Dr. Karen Noble, Head of Research Training and Fellowships, Cancer Research UK, makes …

Relevance of policy in shaping personalised medicine and tackling lung cancer
05 Dec 2016 – 10:16
Relevance of policy in shaping personalised medicine and tackling lung cancer

Policymakers have a significant role to play in bringing about a Europe in which personalised medicine, in all its forms, can be integrated into healthcare systems. Denis Horgan, Executive Director, European Alliance for Personalised Medicine, …

‘Low-dose CT screening best for high-risk patients’
05 Dec 2016 – 10:14
‘Low-dose CT screening best for high-risk patients’

In the European Union, lung cancer is the 4th cancer in incidence with 313,000 new cases per year, but remains the number one killer, accounting to 268,000 deaths per year. Lung cancer represents 21% of all cancer deaths in …

Healthcare stakeholders join hands to fight lung cancer
05 Dec 2016 – 10:13
Healthcare stakeholders join hands to fight lung cancer

The 2016 Lung Cancer Europe Roundtableorganised by the International Centre for Parliamentary Studies took place in Brussels on Tuesday, 27th September. Members of the European Parliament, senior representatives from the World Health Organisation and European …

Illumina Launches TruSight Tumor 170
05 Dec 2016 – 10:00
Illumina Launches TruSight Tumor 170

Illumina’s newest addition in clinical cancer research portfolio aims to establish a standardised method for tumor profiling
Illumina, Inc. has launched TruSight® Tumor 170, a 170 gene next-generation sequencing solution to support the transformation of the …

At the forefront of a new era of clinical research
05 Dec 2016 – 10:00
At the forefront of a new era of clinical research

The International Association for the Study of Lung Cancer is at the beginning of a creative period of bottom-up research activity. Dr. Giorgio Scagliotti, President Elect, IASLC, makes an assessment of the challenges within respiratory …

Treating elderly with lung cancer
02 Dec 2016 – 17:27
Treating elderly with lung cancer

With the European continent aging faster than any other region, evaluation of new drugs in the elderly is becoming a major issue. Dr. Ilona Rousalova, Pulmonologist & Thoracic Surgeon, Czech Lung Cancer Cooperative Group, studies …

Targetting the environmental risk factors of lung cancer
02 Dec 2016 – 17:23
Targetting the environmental risk factors of lung cancer

The European Commission addresses the environmental risk factors of lung cancer through an ambitious tobacco control policy comprising both robust laws regulating tobacco products and prohibiting the advertising and sponsorship of such products. Antoni Monsterrat …